BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 17262024)

  • 1. Fanconi anemia and breast cancer susceptibility.
    Patel KJ
    Nat Genet; 2007 Feb; 39(2):142-3. PubMed ID: 17262024
    [No Abstract]   [Full Text] [Related]  

  • 2. Fanconi anemia is associated with a defect in the BRCA2 partner PALB2.
    Xia B; Dorsman JC; Ameziane N; de Vries Y; Rooimans MA; Sheng Q; Pals G; Errami A; Gluckman E; Llera J; Wang W; Livingston DM; Joenje H; de Winter JP
    Nat Genet; 2007 Feb; 39(2):159-61. PubMed ID: 17200672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biallelic mutations in PALB2 cause Fanconi anemia subtype FA-N and predispose to childhood cancer.
    Reid S; Schindler D; Hanenberg H; Barker K; Hanks S; Kalb R; Neveling K; Kelly P; Seal S; Freund M; Wurm M; Batish SD; Lach FP; Yetgin S; Neitzel H; Ariffin H; Tischkowitz M; Mathew CG; Auerbach AD; Rahman N
    Nat Genet; 2007 Feb; 39(2):162-4. PubMed ID: 17200671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biomedicine. D-Day for BRCA2.
    Witt E; Ashworth A
    Science; 2002 Jul; 297(5581):534. PubMed ID: 12065747
    [No Abstract]   [Full Text] [Related]  

  • 5. Alpha-fetoprotein and Fanconi Anemia: Relevance to DNA Repair and Breast Cancer Susceptibility.
    Lakhi NA; Mizejewski GJ
    Fetal Pediatr Pathol; 2017 Feb; 36(1):49-61. PubMed ID: 27690720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutational analysis of FANCL, FANCM and the recently identified FANCI suggests that among the 13 known Fanconi Anemia genes, only FANCD1/BRCA2 plays a major role in high-risk breast cancer predisposition.
    García MJ; Fernández V; Osorio A; Barroso A; Fernández F; Urioste M; Benítez J
    Carcinogenesis; 2009 Nov; 30(11):1898-902. PubMed ID: 19737859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New complexities for BRCA1 and BRCA2.
    Kerr P; Ashworth A
    Curr Biol; 2001 Aug; 11(16):R668-76. PubMed ID: 11525763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Susceptibility pathways in Fanconi's anemia and breast cancer.
    D'Andrea AD
    N Engl J Med; 2010 May; 362(20):1909-19. PubMed ID: 20484397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fanconi anemia: Fanconi anemia, breast and embryonal cancer risk revisited.
    Howlett NG
    Eur J Hum Genet; 2007 Jul; 15(7):715-7. PubMed ID: 17505525
    [No Abstract]   [Full Text] [Related]  

  • 10. A growing network of cancer-susceptibility genes.
    Venkitaraman AR
    N Engl J Med; 2003 May; 348(19):1917-9. PubMed ID: 12736286
    [No Abstract]   [Full Text] [Related]  

  • 11. Ten genes for inherited breast cancer.
    Walsh T; King MC
    Cancer Cell; 2007 Feb; 11(2):103-5. PubMed ID: 17292821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of Fanconi Anemia genes in familial breast cancer predisposition.
    Seal S; Barfoot R; Jayatilake H; Smith P; Renwick A; Bascombe L; McGuffog L; Evans DG; Eccles D; Easton DF; Stratton MR; Rahman N;
    Cancer Res; 2003 Dec; 63(24):8596-9. PubMed ID: 14695169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emergence of a DNA-damage response network consisting of Fanconi anaemia and BRCA proteins.
    Wang W
    Nat Rev Genet; 2007 Oct; 8(10):735-48. PubMed ID: 17768402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Recent progress in understanding molecular pathogenesis of Fanconi anemia].
    Yamashita T; Oda T; Sekimoto T
    Rinsho Ketsueki; 2009 Jul; 50(7):538-46. PubMed ID: 19638721
    [No Abstract]   [Full Text] [Related]  

  • 15. The two faces of BRCA2, a FANCtastic discovery.
    Stewart G; Elledge SJ
    Mol Cell; 2002 Jul; 10(1):2-4. PubMed ID: 12150898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of FANCB and FANCN/PALB2 fanconi anemia genes in BRCA1/2-negative Spanish breast cancer families.
    García MJ; Fernández V; Osorio A; Barroso A; Llort G; Lázaro C; Blanco I; Caldés T; de la Hoya M; Ramón Y Cajal T; Alonso C; Tejada MI; San Román C; Robles-Díaz L; Urioste M; Benítez J
    Breast Cancer Res Treat; 2009 Feb; 113(3):545-51. PubMed ID: 18302019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Fanconi anemia and DNA-damage response network].
    Matsushita N; Kitao H; Ishiai M; Takata M
    Tanpakushitsu Kakusan Koso; 2009 Mar; 54(4 Suppl):580-5. PubMed ID: 21089513
    [No Abstract]   [Full Text] [Related]  

  • 18. PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene.
    Rahman N; Seal S; Thompson D; Kelly P; Renwick A; Elliott A; Reid S; Spanova K; Barfoot R; Chagtai T; Jayatilake H; McGuffog L; Hanks S; Evans DG; Eccles D; ; Easton DF; Stratton MR
    Nat Genet; 2007 Feb; 39(2):165-7. PubMed ID: 17200668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Global and disease-associated genetic variation in the human Fanconi anemia gene family.
    Rogers KJ; Fu W; Akey JM; Monnat RJ
    Hum Mol Genet; 2014 Dec; 23(25):6815-25. PubMed ID: 25104853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PALB2/FANCN: recombining cancer and Fanconi anemia.
    Tischkowitz M; Xia B
    Cancer Res; 2010 Oct; 70(19):7353-9. PubMed ID: 20858716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.